H

H

H

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
H Live QuoteReal-time
$186.45
+$7.84(+4.39%)1M
Day Range$185.58 – $193.38
Open$192.55
Previous Close$193.74
Volume573.5K
Key Financials & Valuation
Fundamental balance sheet & market metrics
CONSUMER CYCLICAL
Market Cap$18.09B
P/E Ratio (TTM)100.9
Forward P/E35.8
EPS (TTM)$1.92
Price to Book5.6
Dividend Yield0.32%
Beta (Volatility)1.36
IndustryLODGING
52-Week RangeCurrent: $186.45 (71%)
Low: $137.30High: $206.69
Wall Street Consensus
Strong Buy
Analyst Rating
4.8/ 5.0
Target Price
$203.68+35.8% upside

Insider Buys

0

$0

Insider Sales

1

$16.00M

Total Volume

$16.00M

1 transactions

Net Activity

$16.00M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
25CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
H
1

Hoplamazian Mark Samuel

See Remarks

0 buys1 sells

$16.00M total

Trading History
H insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 3, 2026

2 weeks ago

Hoplamazian Mark Samuel

See Remarks

Insider
Sell85.0K$188.23$16.00M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
H Buy Conviction0%
Industry Rank#110 of 570
Volume Contribution0.1%
Total Industry Activity$16.52B

H has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. H ranks #110 in insider activity out of 570 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for H

Over the last 90 days, corporate insiders at H (H) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 1 were sales. The total volume of insider trading reached $16.00M.

The net insider activity for H shows a net selling bias of $16.00M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Hoplamazian Mark Samuel (See Remarks), who traded 85.0K shares valued at $16.00M on Nov 3, 2026.

Live Market News & Developments
Aggregated real-time headlines for H (H)
6 updates

Should Hyatt Hotels (H) Stock Watchers Care About Its New Loyalty Partnership?

Yahoo Finance SingaporeYesterday

Goldman Sachs, Morgan Stanley diverge on 2027 calls for H shares vs A shares

South China Morning Post4d ago

JPMAM launches global equity value strategy

InvestorDaily7h ago

(H) Daily Stock Insights (H:CA)

Stock Traders DailyYesterday

Hyatt Hotels Corporation (H) Stock Forecasts

Yahoo FinanceYesterday

Eligible linked elites can earn Hyatt points on Delta flights and Delta miles at Hyatt hotels.

Stock Titan2d ago

Related News & Analyst Reports

Read original insights and educational research covering H and the Unknown sector.

August 6, 2026

The AI Circular Valuation Bubble: Inside the Venture-Cloud Loop

An in-depth investigation into how technology giants and AI startups engage in circular capital flows, investing venture capital in exchange for cloud services and hardware, creating a closed-loop economy that artificially inflates valuations.

Read Analysis
August 5, 2026

The Biotech Executive Playbook: Tracking Clinical Phase SEC Filings

An empirical study on how clinical-stage biotech executives execute Form 4 open-market purchases ahead of trial data releases, outlining the regulatory gaps and alpha potential of clinical insider tracking.

Read Analysis
August 4, 2026

The Spinoff Separation: Tracking Post-Spinoff Executive Ownership Trends

An investigation of corporate spinoffs, showing how executive equity allocations and post-separation insider transactions signal parent and subsidiary performance trajectories.

Read Analysis
August 3, 2026

The Lockup Expiration Wave: Venture Capital Post-IPO Exit Strategies

A data-driven analysis of how venture capital firms and pre-IPO insiders manage lockup expirations, detailing block trade execution, distribution methods, and stock price impact.

Read Analysis
August 3, 2026

Lock-up Expiration Frontrunning: How Venture Funds Manage Large Block Trades

When lock-up periods expire, venture funds use block trades, 10b-18 programs, and coordinated secondary offerings to exit large positions. This report reveals the strategies that minimize price impact, and how retail investors can track them.

Read Analysis
August 2, 2026

Deciphering Form 5 Filings: Uncovering Annual Insider Gift Trades

A comprehensive guide to SEC Form 5 filings, explaining how annual reports of gift shares, stock options, and non-open-market transactions signal insider sentiment.

Read Analysis

FAQs About H Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for H.

Based on SEC Form 4 disclosures, the Insider Confidence Score for H is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 1 sales by company executives over the last 90 days.

The CEO Conviction Index for H is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.